Alternative‐splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

LM Urbanski, N Leclair… - Wiley Interdisciplinary …, 2018 - Wiley Online Library
Defects in alternative splicing are frequently found in human tumors and result either from
mutations in splicing‐regulatory elements of specific cancer genes or from changes in the …

The double dealing of cyclin D1

G Tchakarska, B Sola - Cell cycle, 2020 - Taylor & Francis
The cell cycle is tightly regulated by cyclins and their catalytic moieties, the cyclin-dependent
kinases (CDKs). Cyclin D1, in association with CDK4/6, acts as a mitogenic sensor and …

[HTML][HTML] Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation

J Wang, W Su, T Zhang, S Zhang, H Lei, F Ma… - Cell Death & …, 2023 - nature.com
Abstract Cyclin D1 (CCND1), a crucial mediator of cell cycle progression, possesses many
mutation types with different mutation frequencies in human cancers. The G870A mutation is …

[HTML][HTML] CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis

MA Augello, D Liu, LD Deonarine, BD Robinson… - Cancer Cell, 2019 - cell.com
Deletion of the gene encoding the chromatin remodeler CHD1 is among the most common
alterations in prostate cancer (PCa); however, the tumor-suppressive functions of CHD1 and …

[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression

AM Blessing, K Rajapakshe, L Reddy Bollu, Y Shi… - Autophagy, 2017 - Taylor & Francis
ABSTRACT AR (androgen receptor) signaling is crucial for the development and
maintenance of the prostate as well as the initiation and progression of prostate cancer …

[HTML][HTML] Function, clinical application, and strategies of Pre-mRNA splicing in cancer

C Di, Syafrizayanti, Q Zhang, Y Chen, Y Wang… - Cell Death & …, 2019 - nature.com
Pre-mRNA splicing is a fundamental process that plays a considerable role in generating
protein diversity. Pre-mRNA splicing is also the key to the pathology of numerous diseases …

[HTML][HTML] Prostate cancer stem cells: the role of androgen and estrogen receptors

E Di Zazzo, G Galasso, P Giovannelli, M Di Donato… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Prostate cancer is one of the most commonly diagnosed cancers in men, and androgen
deprivation therapy still represents the primary treatment for prostate cancer patients. This …

RB loss promotes prostate cancer metastasis

C Thangavel, E Boopathi, Y Liu, A Haber, A Ertel… - Cancer research, 2017 - AACR
RB loss occurs commonly in neoplasia but its contributions to advanced cancer have not
been assessed directly. Here we show that RB loss in multiple murine models of cancer …

[HTML][HTML] Multiple gene aberrations and breast cancer: lessons from super-responders

JJ Wheler, JT Atkins, F Janku, SL Moulder, R Yelensky… - BMC cancer, 2015 - Springer
Background The presence of multiple molecular aberrations in patients with breast cancer
may correlate with worse outcomes. Case Presentations We performed in-depth molecular …